LIFD LFTD PARTNERS INC.
Pharmaceutical Preparations · OTC · SEC CIK 1391135 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-15.9%
TTM net income YoY-53,461.9%
TTM EPS YoY—
Revenue 3-yr CAGR-14.3%
Net income 3-yr CAGR—
Margins
Gross margin8.3%
Operating margin-27.9%
Net margin-108.9%
FCF margin2.1%
EBITDA margin-26.8%
Returns
ROE-164.2%
ROA-127.1%
ROIC (approx.)-38.3%
Asset turnover1.17x
Leverage & solvency
Liabilities / assets55.7%
Debt / equity0.00x
Current ratio1.63x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.02x
Accruals ratio-130.2%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.81M | $8.71M | $9.16M | $8.41M | $9.06M | $10.33M | $9.12M | $8.48M |
| Cost of revenue | $4.17M | $8.05M | $10.86M | $5.42M | $4.90M | $7.08M | $6.91M | $6.42M |
| Gross profit | $641,858 | $651,233 | -$1.71M | $3.00M | $4.16M | $3.25M | $2.22M | $2.06M |
| Operating income | -$2.63M | -$1.53M | -$4.57M | $38,443 | $1.31M | -$109,640 | -$328,386 | $72,318 |
| Interest expense | $20,837 | $21,760 | $21,216 | — | $73,481 | $77,474 | $79,993 | — |
| Pretax income | -$2.52M | -$1.64M | -$4.72M | -$24.59M | $870,814 | -$323,778 | -$382,750 | $3,924 |
| Income tax | $817,139 | -$206,662 | -$555,148 | $330,803 | $236,557 | -$54,828 | -$79,708 | $2,738 |
| Net income | -$3.34M | -$1.44M | -$4.16M | -$24.92M | $634,257 | -$268,950 | -$303,042 | $1,186 |
| EBITDA | -$2.61M | -$1.48M | -$4.43M | $175,124 | $1.37M | -$47,128 | -$188,754 | $208,670 |
| EPS (basic) | -0.23 | -0.10 | -0.28 | — | 0.04 | -0.02 | -0.02 | — |
| EPS (diluted) | -0.23 | -0.10 | -0.28 | — | 0.04 | -0.02 | -0.02 | — |
| Weighted avg. shares (diluted) | 14.82M | 14.82M | 14.82M | — | 14.96M | 14.82M | 14.82M | — |
| Banking | ||||||||
| Deposits | — | — | — | $1.00M | — | — | $1.00M | $1.00M |
| Balance sheet | ||||||||
| Cash & equivalents | $2.49M | $1.50M | $2.09M | $1.77M | $2.92M | $3.12M | $3.28M | $3.15M |
| Receivables | $1.84M | $2.92M | $2.25M | $2.53M | $2.31M | $4.01M | $2.99M | $2.66M |
| Inventory | $2.36M | $3.46M | $5.53M | $10.96M | $10.08M | $9.66M | $9.79M | $9.32M |
| Current assets | $6.80M | $9.38M | $10.26M | $15.69M | $14.59M | $17.88M | $17.42M | $17.23M |
| PP&E, net | $598,017 | $643,021 | $2.10M | $2.27M | $2.38M | $2.51M | $2.64M | $2.70M |
| Goodwill | — | — | — | $0 | $23.09M | $23.09M | $23.09M | $23.09M |
| Intangibles | $5,023 | — | — | $0 | — | — | — | — |
| Total assets | $8.32M | $12.03M | $14.45M | $19.27M | $44.94M | $48.08M | $47.76M | $47.62M |
| Current liabilities | $4.17M | $3.65M | $4.54M | $5.16M | $4.83M | $7.60M | $7.04M | $6.39M |
| Total liabilities | $4.64M | $5.00M | $5.98M | $6.64M | $7.39M | $11.16M | $10.56M | $10.12M |
| Shareholders' equity | $3.68M | $7.03M | $8.47M | $12.63M | $37.56M | $36.93M | $37.20M | $37.50M |
| Shares outstanding | 14.82M | 14.82M | 14.82M | 14.82M | 14.82M | 14.82M | 14.82M | 14.82M |
| Cash flow statement | ||||||||
| Operating cash flow | $374,224 | -$554,945 | $458,860 | $536,315 | $699,045 | -$265,608 | $351,751 | -$892,913 |
| Capital expenditure | -$13,966 | $19,316 | $119,682 | $34,557 | $2,531 | $7,404 | $77,147 | $3,000 |
| Free cash flow | $388,190 | -$574,261 | $339,178 | $501,758 | $696,514 | -$273,012 | $274,604 | -$895,913 |
| Investing cash flow | $1.46M | -$19,316 | -$119,682 | -$34,557 | -$2,531 | -$7,404 | -$77,147 | $1,037 |
| Financing cash flow | -$849,980 | -$12,572 | -$15,171 | -$1.66M | -$891,902 | $109,103 | -$141,590 | -$135,982 |
| Depreciation & amortization | $22,299 | $47,047 | $139,272 | $136,681 | $62,161 | $62,512 | $139,632 | $136,352 |
| Share buybacks | — | — | — | $0 | $0 | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.